E.R. Squibb & Sons, L.L.C.Usage: Yervoy treats multiple advanced cancers in adults and pediatric patients (12+), including melanoma, renal cell carcinoma, MSI-H colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, malignant pleural mesothelioma, and esophageal squamous cell carcinoma—primarily in combination with nivolumab.